{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigtbcvpdufj3tazhgayc26xrnutl6abu4ch2whimx3yk6cg4bidva",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mkx5pchn2d42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicl2ylh346eazb2eajjh7urfmdczgz4wzkise4s7h3igg67u3v5t4"
    },
    "mimeType": "image/jpeg",
    "size": 67130
  },
  "path": "/news/2026-04-blocking-cellular-inflammation-result-effective.html",
  "publishedAt": "2026-05-03T08:00:05.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy. In a new study, published in the Proceedings of the National Academy of Sciences, they show how defective mitochondria within cells spark a process that triggers inflammation. They also show how cancer cells become so dependent on this inflammation to grow that without it, they die.",
  "title": "Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer"
}